Works matching IS 10648542 AND DT 2019 AND VI 28 AND IP 12

Results: 14

Unleashing New Insights from Toxicology Studies: The long-running SEND initiative has fostered new FDA-industry partnerships, opening the door to dramatic changes in toxicology data analysis.

Published in:

Applied Clinical Trials, 2019, v. 28, n. 12, p. 16

By:

Salzman, Sony

Publication type:

Article

Beyond Hard Outcomes: The Next Era in Heart Failure R&D: Why and how FDA is funding a digital biomarkers study that centers on quality of life for patients with heart failure.

Published in:

Applied Clinical Trials, 2019, v. 28, n. 12, p. 18

By:

Rajput, Kuldeep Singh

Publication type:

Article

Submission Considerations for Orphan Product Programs: Examining the unique aspects involved in preparing and submitting marketing applications for proposed treatments for rare disease.

Published in:

Applied Clinical Trials, 2019, v. 28, n. 12, p. 24

By:

Woolson, Rob;
Barber, Kevin

Publication type:

Article

Updates on Drug and Device Regulatory Reform in China: Outlining the nation's key changes and current requirements in processing investigational and new drug applications.

Published in:

Applied Clinical Trials, 2019, v. 28, n. 12, p. 20

By:

Lizuan Chen;
Yumin Li;
Chunyan Liu;
Liu, Daniel

Publication type:

Article

Virtual Clinical Studies: Finding a Path to Execution.

Published in:

Applied Clinical Trials, 2019, v. 28, n. 12, p. 27

By:

Podolsky, Laura

Publication type:

Article

Overcoming Transportation Barriers to Trial Participation: Recruitment study tests the use of a ride-sharing service.

Published in:

Applied Clinical Trials, 2019, v. 28, n. 12, p. 14

By:

Gibaldi, James;
Hastings, Tara;
Kopil, Catherine M.;
Siddiqi, Bernadette;
Whitham, Michelle

Publication type:

Article

CAN RECRUITMENT AND RETENTION GET ANY WORSE?

Published in:

Applied Clinical Trials, 2019, v. 28, n. 12, p. 12

By:

Getz, Ken

Publication type:

Article

HOW DO REGULATORY INTELLIGENCE AND OPERATIONS ENVISION TECHNOLOGY?

Published in:

Applied Clinical Trials, 2019, v. 28, n. 12, p. 11

By:

Dubin, Cindy H.

Publication type:

Article

LABELING CHALLENGES FROM EU ANNEX VI.

Published in:

Applied Clinical Trials, 2019, v. 28, n. 12, p. 10

By:

Jones, Simon;
Alexander, Gordon

Publication type:

Article

NEXT-GENERATION FOCUS IN IMMUNO-ONCOLOGY.

Published in:

2019

By:

Christel, Michael

Publication type:

Interview

LILLY REVAMPS ITS CANCER R&D UNIT.

Published in:: Applied Clinical Trials, 2019, v. 28, n. 12, p. 7
Publication type:: Article

HOW TO BOOST RESEARCH FOR NEW ANTIBIOTICS--AND HOW NOT TO.

Published in:

Applied Clinical Trials, 2019, v. 28, n. 12, p. 6

By:

O'Donnell, Peter

Publication type:

Article

NOVEL STRATEGIES ADVANCED IN 2019 TO INFORM DRUG DEVELOPMENT AND REVIEW.

Published in:

Applied Clinical Trials, 2019, v. 28, n. 12, p. 5

By:

Wechsler, Jill

Publication type:

Article

It Costs What to Do That?

Published in:

Applied Clinical Trials, 2019, v. 28, n. 12, p. 3

By:

HENDERSON, LISA

Publication type:

Article